Reply to Yongbao Wei, Haijian Huang, and Liefu Ye's letter to the editor re: George J. Netto, Mahul B. Amin, Daniel M. Berney, et al. The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs—Part B: Prostate and Urinary Tract Tumors. Eur Urol. 2022;82:469–82

Mark A. Rubin; Mahul B. Amin; Eva Compérat; Anthony Gill; Arndt Hartman; Santosh Menon; Maria Raspollini; John Srigley; Puay Hoon Tan; Satish Ticktoo; Toyonori Tsuzuki; Samra Turajlic; Ian Cree; Daniel Berney; Holger Moch; George J. Netto

doi:10.1016/j.eururo.2022.09.021

Reply to Yongbao Wei, Haijian Huang, and Liefu Ye's letter to the editor re: George J. Netto, Mahul B. Amin, Daniel M. Berney, et al. The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs—Part B: Prostate and Urinary Tract Tumors. Eur Urol. 2022;82:469–82

Mark A. Rubin
, Mahul B. Amin
, Eva Compérat
, Anthony Gill
, Arndt Hartman
, Santosh Menon
, Maria Raspollini
, John Srigley
, Puay Hoon Tan
, Satish Ticktoo
, Toyonori Tsuzuki
, Samra Turajlic
, Ian Cree
, Daniel Berney
, Holger Moch
, George J. Netto

University of Bern
University of Tennessee Health Science Center
University of Southern California
Medical University of Vienna
The University of Sydney
Royal North Shore Hospital
Friedrich-Alexander University Erlangen-Nürnberg
Homi Bhabha National Institute
Azienda Ospedaliera Careggi
University of Toronto
Singapore General Hospital
Memorial Sloan-Kettering Cancer Center
Aichi Medical University
Royal Marsden NHS Foundation Trust
International Agency for Research on Cancer
Queen Mary University of London
Barts Health NHS Trust
University of Zurich
University of Alabama at Birmingham

Research output: Contribution to journal › Article › peer-review

Abstract

We thank Dr. Wei and his esteemed colleagues for their letter highlighting an important issue regarding the terminology of prostate cancer (PCa) with neuroendocrine (NE) features in response to our article in European Urology. We can all agree that pathologists can readily identify small-cell prostate cancer. The utilization of immunohistochemistry for NE markers (eg, synaptophysin and chromogranin) in prostate samples obtained from men with untreated, clinically localized PCa has led to confusion on how to classify such samples when positive expression is encountered in the absence of bona fide small cell features.

Original language	English
Pages (from-to)	e16-e17
Number of pages	2
Journal	European Urology
Volume	83
Issue number	1
DOIs	https://doi.org/10.1016/j.eururo.2022.09.021
Publication status	Published - Jan 2023
Externally published	Yes

Access to Document

10.1016/j.eururo.2022.09.021

Fingerprint

Dive into the research topics of 'Reply to Yongbao Wei, Haijian Huang, and Liefu Ye's letter to the editor re: George J. Netto, Mahul B. Amin, Daniel M. Berney, et al. The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs—Part B: Prostate and Urinary Tract Tumors. Eur Urol. 2022;82:469–82'. Together they form a unique fingerprint.

Cite this

Rubin, M. A., Amin, M. B., Compérat, E., Gill, A., Hartman, A., Menon, S., Raspollini, M., Srigley, J., Tan, P. H., Ticktoo, S., Tsuzuki, T., Turajlic, S., Cree, I., Berney, D., Moch, H., & Netto, G. J. (2023). Reply to Yongbao Wei, Haijian Huang, and Liefu Ye's letter to the editor re: George J. Netto, Mahul B. Amin, Daniel M. Berney, et al. The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs—Part B: Prostate and Urinary Tract Tumors. Eur Urol. 2022;82:469–82. European Urology, 83(1), e16-e17. https://doi.org/10.1016/j.eururo.2022.09.021

Rubin, Mark A. ; Amin, Mahul B. ; Compérat, Eva et al. / Reply to Yongbao Wei, Haijian Huang, and Liefu Ye's letter to the editor re : George J. Netto, Mahul B. Amin, Daniel M. Berney, et al. The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs—Part B: Prostate and Urinary Tract Tumors. Eur Urol. 2022;82:469–82. In: European Urology. 2023 ; Vol. 83, No. 1. pp. e16-e17.

@article{71536b6af50246d4bc0e262535d734d8,

title = "Reply to Yongbao Wei, Haijian Huang, and Liefu Ye's letter to the editor re: George J. Netto, Mahul B. Amin, Daniel M. Berney, et al. The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs—Part B: Prostate and Urinary Tract Tumors. Eur Urol. 2022;82:469–82",

abstract = "We thank Dr. Wei and his esteemed colleagues for their letter highlighting an important issue regarding the terminology of prostate cancer (PCa) with neuroendocrine (NE) features in response to our article in European Urology. We can all agree that pathologists can readily identify small-cell prostate cancer. The utilization of immunohistochemistry for NE markers (eg, synaptophysin and chromogranin) in prostate samples obtained from men with untreated, clinically localized PCa has led to confusion on how to classify such samples when positive expression is encountered in the absence of bona fide small cell features.",

author = "Rubin, \{Mark A.\} and Amin, \{Mahul B.\} and Eva Comp{\'e}rat and Anthony Gill and Arndt Hartman and Santosh Menon and Maria Raspollini and John Srigley and Tan, \{Puay Hoon\} and Satish Ticktoo and Toyonori Tsuzuki and Samra Turajlic and Ian Cree and Daniel Berney and Holger Moch and Netto, \{George J.\}",

year = "2023",

month = jan,

doi = "10.1016/j.eururo.2022.09.021",

language = "English",

volume = "83",

pages = "e16--e17",

journal = "European Urology",

issn = "0302-2838",

publisher = "Elsevier B.V.",

number = "1",

}

Rubin, MA, Amin, MB, Compérat, E, Gill, A, Hartman, A, Menon, S, Raspollini, M, Srigley, J, Tan, PH, Ticktoo, S, Tsuzuki, T, Turajlic, S, Cree, I, Berney, D, Moch, H & Netto, GJ 2023, 'Reply to Yongbao Wei, Haijian Huang, and Liefu Ye's letter to the editor re: George J. Netto, Mahul B. Amin, Daniel M. Berney, et al. The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs—Part B: Prostate and Urinary Tract Tumors. Eur Urol. 2022;82:469–82', European Urology, vol. 83, no. 1, pp. e16-e17. https://doi.org/10.1016/j.eururo.2022.09.021

Reply to Yongbao Wei, Haijian Huang, and Liefu Ye's letter to the editor re: George J. Netto, Mahul B. Amin, Daniel M. Berney, et al. The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs—Part B: Prostate and Urinary Tract Tumors. Eur Urol. 2022;82:469–82. / Rubin, Mark A.; Amin, Mahul B.; Compérat, Eva et al.
In: European Urology, Vol. 83, No. 1, 01.2023, p. e16-e17.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Reply to Yongbao Wei, Haijian Huang, and Liefu Ye's letter to the editor re

T2 - George J. Netto, Mahul B. Amin, Daniel M. Berney, et al. The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs—Part B: Prostate and Urinary Tract Tumors. Eur Urol. 2022;82:469–82

AU - Rubin, Mark A.

AU - Amin, Mahul B.

AU - Compérat, Eva

AU - Gill, Anthony

AU - Hartman, Arndt

AU - Menon, Santosh

AU - Raspollini, Maria

AU - Srigley, John

AU - Tan, Puay Hoon

AU - Ticktoo, Satish

AU - Tsuzuki, Toyonori

AU - Turajlic, Samra

AU - Cree, Ian

AU - Berney, Daniel

AU - Moch, Holger

AU - Netto, George J.

PY - 2023/1

Y1 - 2023/1

N2 - We thank Dr. Wei and his esteemed colleagues for their letter highlighting an important issue regarding the terminology of prostate cancer (PCa) with neuroendocrine (NE) features in response to our article in European Urology. We can all agree that pathologists can readily identify small-cell prostate cancer. The utilization of immunohistochemistry for NE markers (eg, synaptophysin and chromogranin) in prostate samples obtained from men with untreated, clinically localized PCa has led to confusion on how to classify such samples when positive expression is encountered in the absence of bona fide small cell features.

AB - We thank Dr. Wei and his esteemed colleagues for their letter highlighting an important issue regarding the terminology of prostate cancer (PCa) with neuroendocrine (NE) features in response to our article in European Urology. We can all agree that pathologists can readily identify small-cell prostate cancer. The utilization of immunohistochemistry for NE markers (eg, synaptophysin and chromogranin) in prostate samples obtained from men with untreated, clinically localized PCa has led to confusion on how to classify such samples when positive expression is encountered in the absence of bona fide small cell features.

UR - https://www.scopus.com/pages/publications/85143778260

UR - https://go.openathens.net/redirector/westernsydney.edu.au?url=https://doi.org/10.1016/j.eururo.2022.09.021

U2 - 10.1016/j.eururo.2022.09.021

DO - 10.1016/j.eururo.2022.09.021

M3 - Article

C2 - 36202688

AN - SCOPUS:85143778260

SN - 0302-2838

VL - 83

SP - e16-e17

JO - European Urology

JF - European Urology

IS - 1

ER -

Rubin MA, Amin MB, Compérat E, Gill A, Hartman A, Menon S et al. Reply to Yongbao Wei, Haijian Huang, and Liefu Ye's letter to the editor re: George J. Netto, Mahul B. Amin, Daniel M. Berney, et al. The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs—Part B: Prostate and Urinary Tract Tumors. Eur Urol. 2022;82:469–82. European Urology. 2023 Jan;83(1):e16-e17. doi: 10.1016/j.eururo.2022.09.021

Abstract

Access to Document

Other files and links

Fingerprint

Cite this